A review article in a separate publication highlights that the results of this trial may not alter practice. This study mostly included osteoarthritis patients at low cardiovascular risk, and was not designed to address differences in the likelihood of an NSAID interaction with low dose aspirin as a source of bias in favour of celecoxib.